Foster City, CA, United States of America

Rosa P Ubillas

This inventor holds 1 USPTO granted patent. Top assignee: Shaman Pharmaceuticals, Inc.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rosa P Ubillas. Retrieved from https://idiyas.com/inventor/rosa-p-ubillas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rosa P Ubillas: Innovator in Diabetes Treatment

Introduction

Rosa P Ubillas is a notable inventor based in Foster City, CA (US). She has made significant contributions to the field of diabetes treatment through her innovative research and development of novel compounds.

Latest Patents

Ubillas holds a patent for "Terpenoid-type quinones for treatment of diabetes." This patent describes novel terpenoid-type quinones that can be obtained from Pycnanthus spp. The processes for obtaining these quinones and their methods of use as hypoglycemic agents are detailed in her patent. In a preferred embodiment, the terpenoid-type quinones are derived from the leaves and stems of Pycnanthus angolensis. These compounds are particularly useful for treating both insulin-dependent (type I) and non-insulin-dependent (type II) diabetes.

Career Highlights

Rosa P Ubillas is associated with Shaman Pharmaceuticals, Inc., where she has been instrumental in advancing research related to diabetes treatment. Her work has the potential to impact the lives of many individuals suffering from this chronic condition.

Collaborations

Ubillas has collaborated with notable colleagues, including Jolad D Shivanand and Christopher D Mendez, to further her research and development efforts.

Conclusion

Rosa P Ubillas is a pioneering inventor whose work in developing terpenoid-type quinones offers promising avenues for diabetes treatment. Her contributions to the field highlight the importance of innovation in addressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…